Duodenal levodopa infusion: Safety and efficacy in a 6 years outpatient follow-up
Objective: To reduce the risk of adverse events and dropout rate in patients. Background: Duodenal levodopa infusion (DLI) is used for the treatment of advanced…Exercise-induced adaptive neuroplasticity in the MPTP mouse model of Parkinson’s disease
Objective: To increase our understanding of how physical exercise may drive adaptive neuroplasticity in a mouse model of Parkinson's disease (PD). Background: PD is a…Mobile decision support system for nurse managment of deep brain stimulation
Objective: To decrease time spent on deep brain stimulation (DBS) programming while improving quality of life for patients and caregivers by providing nurses with an…Critical path for Parkinson’s, I: Data sharing and regulatory science in catalyzing innovation for Parkinson’s disease
Objective: This presentation highlights a new precompetitive consortium based strategy for the successful development of regulatory-endorsed biomarkers and quantitative drug development platforms targeted at the…Feasibility and preliminary efficacy of a telehealth approach to group tango instruction for people with Parkinson’s disease
Objective: To determine the feasibility and preliminary efficacy of group adapted tango class for individuals with Parkinson's disease (PD) taught through telehealth technology. Background: Group…Blindfolded balance training in patients with Parkinson’s disease: A sensory-motor strategy to improve the gait
Objective: Recent evidence suggested that the use of treadmill training may improve gait parameters, such as gait speed and stride length. Visual deprivation could engage…Objective measures of Parkinsonian motor symptoms using a continuously worn smartwatch
Objective: To determine whether smartwatch sensor data correlates with clinician-measured Parkinson's disease symptoms. Background: Data collected with smartwatches could be used for long-term, continuous assessment…Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
Objective: To evaluate baseline predictors and longitudinal impact of amantadine use in Parkinson's disease (PD). Background: There is preclinical data that amantadine has neuroprotective properties,…Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion
Objective: To describe the postmortem findings from two patients who underwent intraputaminal infusion of glial-derived neurotrophic factor (GDNF). Background: GDNF has been shown to have…Fox insight wear ecosystem: using mobile technology and cloud-based computing to support PD research
Objective: To enable a simple strategy for the continuous collection and analysis of sensory data from Parkinson's disease (PD) patients that can increase the effectiveness…